ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "MDT perspectives on biologic treatment selection in severe type 2 asthma"
Episode Synopsis
touchMDT for touchIMMUNOLOGY
Listen to key experts from a multidisciplinary team explore the use of endotyping and biomarkers in guiding biologic treatment selection for patients with severe type 2 asthma.
The multidisciplinary team
Allergist: Professor Ioana Agache, Romania
Primary care physician: Professor Barbara Yawn, USA
Pulmonologist: Professor Alberto Papi, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care//
Listen to key experts from a multidisciplinary team explore the use of endotyping and biomarkers in guiding biologic treatment selection for patients with severe type 2 asthma.
The multidisciplinary team
Allergist: Professor Ioana Agache, Romania
Primary care physician: Professor Barbara Yawn, USA
Pulmonologist: Professor Alberto Papi, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care//
In God we trust